Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 19 Jan 2012  |  Global  |  Technology Research

    Advances in Pharmacovigilance Techniques--Technology Benchmarking and Stakeholder Analysis (Technical Insights)

    A Drug Safety Toolkit Moving toward Improved Drug Safety Systems

    Pharmacovigilance activities revolve around ensuring drug safety and preventing adverse drug reactions. While post marketing studies form the core of pharmacovigilance, inclusion of safety measures during clinical development and carrying out additional post marketing active surveillance is being utilized by a number of pharma companies.  Risks ...

    $4,950.00
  2. 15 May 2012  |  North America  |  Market Research

    Mölnlycke Health Care—Company Profile

    This market insight provides an overview of Mölnlycke Health Care. The Mölnlycke company was established in 1849 by G.F. Henning as primarily a textile manufacturer. In 1997, Mölnlycke Health Care came in to existence when Nordic Capital acquired the medical devices segment of SCA. The company is currently owned by Investor AB and has seen stea...

    $1,500.00
  3. 31 Aug 2012  |  Asia Pacific  |  Market Research

    Strategic Analysis of Contract Research and Manufacturing Services Market in India

    Presenting Opportunities for Market Share Gain

    This study provides a comprehensive analysis of the contract research and manufacturing services (CRAMS) segment in India by focusing on drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectables. The study is based on detailed primary research, and includes an evaluation of the market size as ...

    $4,950.00
  4. 23 Jan 2013  |  South Asia, Middle East & North Africa  |  Market Research

    Overview of the In-vitro Diagnostics Market in India

    This research service provides a detailed analysis of the in-vitro diagnostics market in India. It quantifies the market size, provides insight into the disease burden of India, and examines market dynamics from 2011 to 2018. It also provides an in-depth analysis of the competitive environment through analysis of the competitive structure, the diag...

    $4,950.00
  5. 01 Feb 2013  |    |  Market Research

    Strategic Analysis of Vaccine Market in India

    This research service examines and highlights the prevailing and the emerging trends of the Indian vaccine market to comprehend the market dynamics and identify the hidden potential growth segments. The primary objective of the study is to provide details about the overall market, including trends, and drivers and restraints. In addition, market se...

    $6,950.00
  6. This issue of Vital Signs discusses the change in 2015 Mammogram Guidelines, NeoGenomics' acquistion of Clarient from GE, and Tute Genomics' acquisition of Knome.

    $1,500.00
  7. 28 Feb 2013  |  Europe  |  Market Research

    Image-Guided and Robot-Assisted Surgery Market in Western Europe

    Market Grows Despite Skepticism Over Proven Advantages of Robotics

    The research service examines the image-guided and robot-assisted surgery market in Western Europe, covering the United Kingdom, Germany, France, Italy, Spain, Benelux, and Scandinavia. The analysis includes market dynamics, revenue forecasts, market share, and competitive structure. The market has been segmented as: surgical imaging systems (SIS),...

    $4,950.00
  8. 04 Mar 2013  |  North America  |  Market Research

    Analysis of the U.S. Magnetic Resonance Imaging (MRI) Systems Market

    An Assessment and Outlook through 2016

    This research service evaluates the U.S. MRI systems market during the 2008 to 2016 time period. It provides analyses of the less than or equal to 1.5 Tesla and 3.0 Tesla market segments at the total market and individual segment levels. Content in this research service includes market background, technology trends, market drivers and restraints, a...

    $4,950.00
  9. 18 Mar 2013  |  South Asia, Middle East & North Africa  |  Market Research

    Indian Diabetes Market

    This research service studies the Indian Diabetes market. It provides the number of Type 1 and Type 2 diabetic patients in India across different age groups and forecasts these numbers up to 2030. It provides a detailed analysis of the two major segments of the market, the insulin market segment and the anti-diabetic medications segment, which incl...

    $4,950.00
  10. 28 Mar 2013  |  Latin America  |  Market Research

    Brazilian Medical Imaging Market Outlook for CT, MRI, and Ultrasound

    Governmental Programs and Investments Stimulate the Market

    This study analyzes the Brazilian medical imaging market from 2011 to 2017, focusing exclusively on computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. The analyzed total market is expected to growth with a single-digit CAGR for 2012 to 2017. This growth rate is mainly driven by the C-class economic growth that allows increa...

    $10,000.00